OKYO Pharma Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by OKYO Pharma Ltd on September 9, 2026. The filing serves to announce the Company's scheduled presentations at the Ophthalmology Futures Forum and the 5th Annual ESCRS iNovation Day. The registrant is a foreign private issuer filing under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event announcement and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely discloses upcoming corporate events.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of participation in industry forums. The filing explicitly states that the attached news announcement (Exhibit 99.1) is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. No specific guidance, risks, or contingencies are detailed in the text of the Form 6-K itself.
Key Facts for Investor Verification
- The Company plans to present at the Ophthalmology Futures Forum and the 5th Annual ESCRS iNovation Day.
- The specific details of the presentations are contained in Exhibit 99.1, which is furnished but not filed.
- This filing contains no financial data; investors should refer to the most recent Form 20-F for financial performance.
- The report is incorporated by reference into the Company's Registration Statement on Form F-3 (Reg. No. 333-293145).